Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Durvalumab
Related studies linked through entity extraction aliases.
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Renal Adjuvant MultiPle Arm Randomised Trial
- Status
- RECRUITING
- Phase
- PHASE3
PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
- Status
- UNKNOWN
- Phase
- PHASE1
Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition
- Status
- TERMINATED
- Phase
- PHASE1
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Durvalumab in DLBCL After Autologous Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL
- Status
- WITHDRAWN
- Phase
- PHASE2
A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
- Status
- TERMINATED
- Phase
- PHASE1